110 related articles for article (PubMed ID: 35216969)
1. Turnover of the mTOR inhibitor, DEPTOR, and downstream AKT phosphorylation in multiple myeloma cells, is dependent on ERK1-mediated phosphorylation.
Vega M; Chen Y; Shi Y; Gera J; Lichtenstein A
J Biol Chem; 2022 Apr; 298(4):101750. PubMed ID: 35216969
[TBL] [Abstract][Full Text] [Related]
2. A Novel Therapeutic Induces DEPTOR Degradation in Multiple Myeloma Cells with Resulting Tumor Cytotoxicity.
Vega MI; Shi Y; Frost P; Huerta-Yepez S; Antonio-Andres G; Hernandez-Pando R; Lee J; Jung ME; Gera JF; Lichtenstein A
Mol Cancer Ther; 2019 Oct; 18(10):1822-1831. PubMed ID: 31395691
[TBL] [Abstract][Full Text] [Related]
3. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
Zhang HR; Chen JM; Zeng ZY; Que WZ
J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505
[TBL] [Abstract][Full Text] [Related]
4. DEPTOR is an mTOR inhibitor frequently overexpressed in multiple myeloma cells and required for their survival.
Peterson TR; Laplante M; Thoreen CC; Sancak Y; Kang SA; Kuehl WM; Gray NS; Sabatini DM
Cell; 2009 May; 137(5):873-86. PubMed ID: 19446321
[TBL] [Abstract][Full Text] [Related]
5. DEPTOR promotes survival of cervical squamous cell carcinoma cells and its silencing induces apoptosis through downregulating PI3K/AKT and by up-regulating p38 MAP kinase.
Srinivas KP; Viji R; Dan VM; Sajitha IS; Prakash R; Rahul PV; Santhoshkumar TR; Lakshmi S; Pillai MR
Oncotarget; 2016 Apr; 7(17):24154-71. PubMed ID: 26992219
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic Properties of a DEPTOR-mTOR Inhibitor in Multiple Myeloma Cells.
Shi Y; Daniels-Wells TR; Frost P; Lee J; Finn RS; Bardeleben C; Penichet ML; Jung ME; Gera J; Lichtenstein A
Cancer Res; 2016 Oct; 76(19):5822-5831. PubMed ID: 27530328
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of DEPTOR induces apoptosis, increases chemosensitivity to doxorubicin and suppresses autophagy in RPMI-8226 human multiple myeloma cells in vitro.
Zhang H; Chen J; Zeng Z; Que W; Zhou L
Int J Mol Med; 2013 May; 31(5):1127-34. PubMed ID: 23503641
[TBL] [Abstract][Full Text] [Related]
8. Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors.
Dworakowska D; Wlodek E; Leontiou CA; Igreja S; Cakir M; Teng M; Prodromou N; Góth MI; Grozinsky-Glasberg S; Gueorguiev M; Kola B; Korbonits M; Grossman AB
Endocr Relat Cancer; 2009 Dec; 16(4):1329-38. PubMed ID: 19620247
[TBL] [Abstract][Full Text] [Related]
9. Akt2 causes TGFβ-induced deptor downregulation facilitating mTOR to drive podocyte hypertrophy and matrix protein expression.
Das F; Ghosh-Choudhury N; Lee DY; Gorin Y; Kasinath BS; Choudhury GG
PLoS One; 2018; 13(11):e0207285. PubMed ID: 30444896
[TBL] [Abstract][Full Text] [Related]
10. mTOR drives its own activation via SCF(βTrCP)-dependent degradation of the mTOR inhibitor DEPTOR.
Gao D; Inuzuka H; Tan MK; Fukushima H; Locasale JW; Liu P; Wan L; Zhai B; Chin YR; Shaik S; Lyssiotis CA; Gygi SP; Toker A; Cantley LC; Asara JM; Harper JW; Wei W
Mol Cell; 2011 Oct; 44(2):290-303. PubMed ID: 22017875
[TBL] [Abstract][Full Text] [Related]
11. DEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemia.
Hu Y; Su H; Liu C; Wang Z; Huang L; Wang Q; Liu S; Chen S; Zhou J; Li P; Chen Z; Liu H; Qing G
Oncogene; 2017 Feb; 36(8):1038-1047. PubMed ID: 27593934
[TBL] [Abstract][Full Text] [Related]
12. DEPTOR suppresses the progression of esophageal squamous cell carcinoma and predicts poor prognosis.
Ji YM; Zhou XF; Zhang J; Zheng X; Li SB; Wei ZQ; Liu T; Cheng DL; Liu P; Song K; Tan T; Zhu H; Guo JL
Oncotarget; 2016 Mar; 7(12):14188-98. PubMed ID: 26893358
[TBL] [Abstract][Full Text] [Related]
13. Regulation of D-cyclin translation inhibition in myeloma cells treated with mammalian target of rapamycin inhibitors: rationale for combined treatment with extracellular signal-regulated kinase inhibitors and rapamycin.
Frost P; Shi Y; Hoang B; Gera J; Lichtenstein A
Mol Cancer Ther; 2009 Jan; 8(1):83-93. PubMed ID: 19139116
[TBL] [Abstract][Full Text] [Related]
14. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK.
Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225
[TBL] [Abstract][Full Text] [Related]
15. Mammalian target of rapamycin inhibitors activate the AKT kinase in multiple myeloma cells by up-regulating the insulin-like growth factor receptor/insulin receptor substrate-1/phosphatidylinositol 3-kinase cascade.
Shi Y; Yan H; Frost P; Gera J; Lichtenstein A
Mol Cancer Ther; 2005 Oct; 4(10):1533-40. PubMed ID: 16227402
[TBL] [Abstract][Full Text] [Related]
16. mTOR generates an auto-amplification loop by triggering the βTrCP- and CK1α-dependent degradation of DEPTOR.
Duan S; Skaar JR; Kuchay S; Toschi A; Kanarek N; Ben-Neriah Y; Pagano M
Mol Cell; 2011 Oct; 44(2):317-24. PubMed ID: 22017877
[TBL] [Abstract][Full Text] [Related]
17. DEPTOR, an mTOR inhibitor, is a physiological substrate of SCF(βTrCP) E3 ubiquitin ligase and regulates survival and autophagy.
Zhao Y; Xiong X; Sun Y
Mol Cell; 2011 Oct; 44(2):304-16. PubMed ID: 22017876
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship study of small molecule inhibitors of the DEPTOR-mTOR interaction.
Lee J; Shi Y; Vega M; Yang Y; Gera J; Jung ME; Lichtenstein A
Bioorg Med Chem Lett; 2017 Oct; 27(20):4714-4724. PubMed ID: 28916338
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine phosphorylation of DEPTOR functions as a molecular switch to activate mTOR signaling.
M Gagné L; Morin N; Lavoie N; Bisson N; Lambert JP; Mallette FA; Huot MÉ
J Biol Chem; 2021 Nov; 297(5):101291. PubMed ID: 34634301
[TBL] [Abstract][Full Text] [Related]
20. Dienogest enhances autophagy induction in endometriotic cells by impairing activation of AKT, ERK1/2, and mTOR.
Choi J; Jo M; Lee E; Lee DY; Choi D
Fertil Steril; 2015 Sep; 104(3):655-64.e1. PubMed ID: 26051103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
